Weiss Multi Strategy Advisers LLC Novo Nordisk A S Transaction History

Weiss Multi Strategy Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $576,275 - $692,279	-6,565 Reduced 11.87%	48,737 $5.04 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $3.39 Million - $7.43 Million	37,244 Added 206.25%	55,302 $5.03 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $8,890 - $9,841	-57 Reduced 0.31%	18,058 $2.92 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $2.4 Million - $2.88 Million	18,115 New	18,115 $2.88 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $616,136 - $726,962	5,968 New	5,968 $665,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.